Rational pharmacotherapy of chronic heart failure with increased endothelin-1 activity: beta-adrenoblocker nebivolol place

Aim. To optimize chronic heart failure (CHF) pharmacotherapy, basing on endothelin (ET) system activity, functional and cardio-hemodynamic parameters, and their dynamics in beta-adrenoblocker nebivolol therapy. Material and methods. The study included 52 patients with coronary heart disease and syst...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: L. I. Olbinskaya, Yu. I. Naymann
Natura: Artigo
Lingua:Russo
Pubblicazione: «SILICEA-POLIGRAF» LLC 2007-02-01
Serie:Кардиоваскулярная терапия и профилактика
Soggetti:
chronic heart failure
pulmonary hypertension
endothelin
nebivolol
Accesso online:https://cardiovascular.elpub.ru/jour/article/view/1145
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi